Why the study?
Does genetic testing identify sarcomere mutations in patients with cardiomyopathy and left ventricular hypertrabeculation?
Population
3 patients referred for evaluation of left ventricular dysfunction and noncompaction of the left ventricle
Design
Case_series
Authors
Loading...
May support sarcomere gene testing in cardiomyopathy with hypertrabeculation; hypothesis-generating and requires validation.
Does genetic testing identify sarcomere mutations in patients with cardiomyopathy and left ventricular hypertrabeculation?
Sarcomere mutations can be identified via genetic testing in patients presenting with cardiomyopathy and left ventricular hypertrabeculation, supporting its clinical utility in this population.
Dellefave et al. (2009) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: